FIELD: medicine; pulmonology. SUBSTANCE: patient's blood is subjected to chemiluminescence analysis in order to determine chemiluminescent indices characterizing generation of active forms of oxygen in system with luminol (basal chemiluminescent index) and oxygen generated by reaction promoted by silicon dioxide (stimulated chemiluminescent index). Analysis is carried out on leucocytes suspended in buffer-diluted physiological solution and in own blood plasma. Analysis is carried out before and after exposing patient's blood to effect 8% of CO and 20% of CO. Variations is indices are calculated and their decline down to 30% is assumed to be equal to 1, down to 30-60% - to 2, and decline below 60% - to 3, total number of indices being 8. Sum total of 22-24 represents indication for hypercapnotherapy, whereas sum total of 19 and less testifies to potentially low efficiency of hypercapnotherapy. EFFECT: higher efficiency. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE COURSE OF BRONCHIAL ASTHMA | 1992 |
|
RU2038599C1 |
METHOD OF FORECASTING COURSE OF BRONCHIAL ASTHMA | 1991 |
|
RU2012884C1 |
METHOD FOR DETERMINING CARBON DIOXIDE INFLUENCE ON PHAGOCYTES SUPEROXIDE ANION RADICAL PRODUCTION | 1993 |
|
RU2108572C1 |
METHOD FOR DETERMINING LEUKOCYTARY GENERATION OF ACTIVE OXYGEN FORMS | 1992 |
|
RU2042949C1 |
METHOD FOR PREDICTION OF AGGRAVATED BRONCHIAL ASTHMA DURATION | 2010 |
|
RU2446400C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2011 |
|
RU2469332C1 |
METHOD FOR PREDICTING SYNDROME OF RESPIRATORY MUSCULATURE FATIGUE IN PATIENTS WITH BRONCHIAL ASTHMA | 2000 |
|
RU2199948C2 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
METHOD OF TREATMENT OF STEROID-DEPENDENT BRONCHIAL ASTHMA | 2007 |
|
RU2348431C1 |
INHALATION COMPOSITION FOR BRONCHIAL ASTHMA TREATMENT | 1992 |
|
RU2054932C1 |
Authors
Dates
1997-08-27—Published
1993-12-21—Filed